From IKEA to eye-opening health campaigns, S&S Wellness' CCO helps turn emotion into action.
The association said it is preparing for new FDA approvals for therapies that treat central nervous system and muscular system diseases.
Every agency in the biz claims to have a "unique" culture and one that fuels a great deal of its success.
The successes of these pharma execs show that there's no one path to professional bliss.
Now that Facebook, Apple, and Google have set their sights on healthcare, agencies find themselves under pressure from yet another flank.
The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.
The best marketers possess a mix of scientific know-how, digital dexterity, and unflappability. To keep them, agencies need to revise their thinking and tactics.
Aaron Sklar, formerly of Welltok, replaces Christine Armstrong, who moved on to a Silicon Valley health startup.
Guidemark Health's Tina Fascetti offers Medela's Katie Busse advice on being a working mother in healthcare marketing.
Incisive Health will next month welcome Francesca Scassellati Sforzolini as head of its Brussels office.
She is director of OTC brand marketing at Dr. Reddy's Laboratories.
The agency appointed Sonja Foster-Storch, previously president of McCann Echo, to fill a role that has been vacant since 2016.
Both positions were newly created as the agency has grown over the past year.
Calman is joining the technology company as VP of comms for Watson Health.
A mentor once told him to keep learning and stay out of his comfort zone.
She will also continue to serve as president of the Astellas U.S.A. Foundation.
Former Edelman executive Mary Corcoran replaces Annalise Coady, who becomes president of W2O EMEA.
Celgene and Agios secure FDA approval for AML drug Idhifa; GSK hires chief digital and technology officer; Pfizer wants tax reform before M&A engagement
David Musselman and Lynn Gerber are now leading sales for the company's primary care and specialty products.
Novartis raises Alcon forecast; UDG acquires Cambridge BioMarketing; Spark Therapeutics receives priority review for Luxturna gene therapy
AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge
When you've figured out the difference, people will walk through fire for you, a mentor once told her.
The CEOs of the industry's largest holding companies discuss how they're reasserting their businesses.
Walgreens ends merger with Rite Aid; Biogen hires former Novartis exec as SVP of corporate affairs; FDA takes new measures to drive drug pricing competition
Zaritsky succeeds Jay Bolling, who becomes executive chairman
The executive director of oncology marketing is fascinated by the resilience of the human body.
Brian Goff is expected to replace Carsten Thiel in June. The drugmaker said Tuesday that Thiel along with several other execs would be leaving the firm.
Holly Henry, previously chief medical officer at FCB Health, will oversee medical strategy in the newly created role.
Alexion names former Baxalta head as CEO; U.S. dollar drops after AHCA-fail; EMA advises suspension of 300 generic drugs by Indian drugmaker
P&G's Mark Chakravarty has joined pharma giant Novartis in a senior role.